| Literature DB >> 31312620 |
Nimet Yılmaz1, Meltem Koruk Özer2.
Abstract
Background and Aims: The cag A and vac A genes of Helicobacter pylori (H. pylori) are closely associated with the pathogenicity of bacteria. However, the significance of H. pylori babA, homB, aspA, and sabA genes is not clear in phenotypic characteristics of virulence. This study aimed to investigate the frequency and importance of these genes in patients with H. pylori positive peptic ulcer (PU). Materials andEntities:
Mesh:
Substances:
Year: 2019 PMID: 31312620 PMCID: PMC6595381 DOI: 10.1155/2019/1271872
Source DB: PubMed Journal: Can J Gastroenterol Hepatol ISSN: 2291-2789
Figure 1Characterization of virulence factors of H. pylori by PCR. Each lane shows different virulence factors of H. pylori strain isolated from human samples. M: Marker, A: babA (2192 bp), B: cagA (1741 bp), C: VacA (1624 bp), D: AspA (1401 bp), E: HomB (1005 bp), and F: sabA (187 bp).
Figure 2PCR application of the biopsy samples taken from H. pylori positive patients with nonulcer and gastric ulcer samples. The presence of AspA (a), BabA (b), VacA (c), HomB (d), CagA (e), and SabA (f) genes in nonulcer and gastric ulcer samples by using PCR. (g) The comparison of H. pylori virulence factors in normal and gastric ulcer samples.
| Primer | Primer sequence | Annealing Temperature (°C) | Primer Length | Product Size (bp) |
|---|---|---|---|---|
| AspA-F | ATGCGTATGGAGCATGATTTCATT | 55.9 | 24 | 1401 |
| AspA-R | TTTATGCTTTTTGAAAGCGTGAGGGCTT | 62.2 | 28 | |
|
| ||||
| BabA-F | ATGAAAAAACACATCCTTTCATTA | 52.5 | 24 | 2192 |
| BabA-R | TTATTCAAATACACGCTATAGAGTCTT | 57.4 | 27 | |
|
| ||||
| CagA-F | AATACACCAACGCCTCCAAG | 57.3 | 20 | 1741 |
| CagA-R | GCTGACAAAGGAGCACTTCC | 59.4 | 20 | |
|
| ||||
| HomB-F | TACAGACGCTCAAGGCAATG | 57.3 | 20 | 1005 |
| HomB-R | TCTATGGGTAGGGCGTTTTG | 57.3 | 20 | |
|
| ||||
| SabA-F | CTCTCTCTCGCTTGCGGTAT | 59.4 | 20 | 187 |
| SabA-R | TTGAATGCTTTGCCTCAATG | 53.2 | 20 | |
|
| ||||
| VacA-F | ACAAACACACCGCAAAATCA | 53.2 | 20 | 1624 |
| VacA-F | AACGGCCACATTAGTGGAAG | 57.3 | 20 | |
| Gender | Kind of disease | Number of patients | AspA+ | BabA+ | CagA+ | HomB+ | SabA+ | VacA+ | Mean Age |
|---|---|---|---|---|---|---|---|---|---|
| Male | NS | 21 | 16 | 3 | 2 | 1 | 2 | 4 | 39.85±17.11 |
| GU | 20 | 15 | 6 | 0 | 0 | 1 | 6 | 49.4±17.82 | |
| Female | NS | 25 | 18 | 5 | 1 | 1 | 3 | 4 | 47.52±17.01 |
| GU | 16 | 9 | 3 | 0 | 1 | 0 | 6 | 45.93±12.28 |
| NS | GU | Total |
| |
|---|---|---|---|---|
| Number of patients | 46 | 36 | 82 | - |
|
| 34 (73.91%) | 25 (69.44%) | 59 (71.95%) | <0.05 |
|
| 7 (15.21%) | 9 (25%) | 16 (19.51%) | ns |
|
| 3 (6.52%) | 0 (0%) | 3 (3.65%) | ns |
|
| 2 (4.34%) | 1 (2.77%) | 3 (3.65%) | ns |
|
| 5 (10.86%) | 1 (2.77%) | 6 (7.31%) | ns |
|
| 12 (26.08%) | 8 (22.22%) | 20 (24.39%) | ns |
| Comparison |
| 95% CI |
|---|---|---|
|
| ns | -0.18 to 0.13 |
|
| ns | -0.14 to 0.16 |
|
| <0.0001 | 0.50 to 0.81 |
|
| <0.05 | 0.002 to 0.31 |
|
| <0.05 | 0.002 to 0.314 |
|
| ns | -0.11 to 0.19 |
|
| <0.0001 | 0.52 to 0.83 |
|
| <0.05 | 0.02 to 0.33 |
|
| <0.05 | 0.02 to 0.33 |
|
| <0.0001 | 0.49 to 0.80 |
|
| ns | -0.009 to 0.302 |
|
| ns | -0.009 to 0.302 |
|
| <0.0001 | -0.65 to -0.34 |
|
| <0.0001 | -0.65 to -0.34 |
|
| ns | -0.15 to 0.15 |
| NS | GU | |
|---|---|---|
|
| <0.0001 | <0.0001 |
|
| <0.001 | <0.001 |
|
| <0.001 | >0.05 |
|
| <0.001 | <0.001 |
|
| <0.001 | <0.001 |
|
| <0.001 | <0.001 |